Pyxis Oncology, Inc. (PYXS) has 16 open-market insider trades by 8 insiders since 2021. The most active filer is Pamela Ann Connealy, COO & CFO.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Mark Chin | — | — | 2 | $15.6M | 2022-04-21 |
| Pfizer Inc. | 10% Owner | — | 1 | $10.0M | 2023-03-17 |
| Cormorant Asset Management, LP | Dir | — | 1 | $7.2M | 2021-10-13 |
| Pamela Ann Connealy | COOCFO | — | 5 | $230K | 2024-11-26 |
| Thomas Civik | Dir | — | 1 | $200K | 2023-03-24 |
| Darren S. Cline | Dir | — | 1 | $94K | 2024-03-26 |
| Lara Sullivan | Pres | — | 2 | $81K | 2023-09-18 |
| Jitendra Wadhane | — | — | 3 | $18K | 2026-03-24 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Jakob Dupont | Director | Sell | $107K | 2026-06-30 |
| Rachel Humphrey | Director | Sell | $32K | 2025-04-14 |
| Pamela Ann Connealy | COO & CFO | Buy | $174K | 2024-11-26 |
| Pamela Ann Connealy | CFO and COO | Buy | $15K | 2023-09-28 |
| Jitendra Wadhane | Chief Accounting Officer | Buy | $5K | 2023-09-27 |
| Pamela Ann Connealy | CFO and COO | Buy | $12K |
Companies that share insiders with PYXS, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2023-09-27 |
| Pamela Ann Connealy | CFO and COO | Buy | $20K | 2023-09-25 |
| Jitendra Wadhane | Chief Accounting Officer | Buy | $9K | 2023-09-25 |
| Jitendra Wadhane | Chief Accounting Officer | Buy | $4K | 2023-09-22 |
| Pamela Ann Connealy | CFO and COO | Buy | $9K | 2023-09-22 |
| Lara Sullivan | President | Sell | $18K | 2023-09-14 |
| Lara Sullivan | President | Sell | $63K | 2023-09-11 |
| Pfizer Inc. | 10% Owner | Buy | $10.0M | 2023-03-17 |
| Mark Chin | — | Sell | $10.6M | 2022-04-21 |
| Darren S. Cline | Director | Buy | $94K | 2021-12-08 |